Regeneron

All the email addresses for regeneron.com
{first}.{last}@regeneron.com
152 email addresses
20+ sources
http://prnewswire.com/news-releases/regeneron-reports-first-quarter-2012-financial-and-operating-results-149024265.html January 1, 2015
http://prnewswire.com/news-releases/regeneron-reports-fourth-quarter-and-full-year-2012-financial-and-operating-results-191179371.html March 3, 2015
http://drugs.com/clinical_trials/sanofi-aventis-regeneron-report-positive-phase-iii-results-zaltrap-aflibercept-second-line-11621.html March 3, 2016
http://drugs.com/clinical_trials/positive-phase-2b-results-sarilumab-rheumatoid-arthritis-presented-late-breaking-poster-2011-12563.html April 4, 2015
http://de.sys-con.com/node/2534519 March 3, 2016
http://bio-medicine.org/medicine-technology-1/regeneron-announces-march-2011-investor-conference-presentations-14919-1 March 3, 2016
http://sanofi.de/l/de/de/layout.jsp August 8, 2015
http://prnewswire.com/news-releases/regeneron-announces-receipt-of-hart-scott-rodino-notice-190674041.html January 1, 2015
http://biospace.com/collaborative/News/regeneron-pharmaceuticals-inc-bayer-healthcare/242583 March 3, 2015
http://biospace.com/news_print.aspx May 5, 2015
http://thenumbers.marketplace.org/publicradio/news/read/23130453/regeneron_recommends_rejection_of_mini April 4, 2015
http://au.sys-con.com/node/2534519 January 1, 2015
http://newsroom.regeneron.com/releasedetail.cfm July 7, 2015
http://prnewswire.com/news-releases/regeneron-reports-third-quarter-2012-financial-and-operating-results-175567551.html January 1, 2015
http://bio-medicine.org/medicine-technology-1/regeneron-pharmaceuticals-announces-pricing-of-offering-of-convertible-senior-notes-due-october-1--2016-21180-1 March 3, 2016
http://drugs.com/clinical_trials/sanofi-regeneron-report-positive-phase-2b-trial-results-sarilumab-rheumatoid-arthritis-12112.html March 3, 2016
http://drugs.com/clinical_trials/sanofi-regeneron-report-phase-2-data-potential-first-class-lipid-lowering-pcsk9-antibody-13223.html May 5, 2017
http://thestreet.com/story/11331461/5/two-year-results-of-phase-3-studies-with-eylea-aflibercept-injection-in-wet-amd-show-sustained-improvement-in-visual-acuity.html January 1, 2015
http://biospace.com/collaborative/news/rockefeller-university-president-marc-tessier/241447 January 1, 2015
http://bio-medicine.org/medicine-technology-1/vegf-trap-eye-submitted-for-eu-marketing-authorization-for-treatment-of-wet-age-related-macular-degeneration-17903-1 March 3, 2016
http://br.sys-con.com/node/2534519 January 1, 2015
http://bio-medicine.org/medicine-technology-1/regeneron-to-report-fourth-quarter-and-full-year-2012-financial-and-operating-results-and-host-conference-call-and-webcast-on-february-14--2013-29934-1 March 3, 2016
http://drugs.com/clinical_trials/two-year-results-phase-3-studies-eylea-aflibercept-wet-amd-show-sustained-improvement-visual-acuity-12749.html March 3, 2016
http://biospace.com/news/regeneron-pharmaceuticals-inc-wins-fda-approval/241335 January 1, 2015
http://fiercebiotech.com/biotech/regeneron-announces-receipt-of-hart-scott-rodino-notice May 5, 2017
http://prnewswire.com/news-releases/regeneron-to-report-fourth-quarter-and-full-year-2012-financial-and-operating-results-and-host-conference-call-and-webcast-on-february-14-2013-188727991.html January 1, 2015
http://biospace.com/news/regeneron-pharmaceuticals-inc-announces-upcoming/287954/source=morenews January 1, 2015
http://investor.regeneron.com/releasedetail.cfm July 7, 2015
http://thestreet.com/story/11169001/2/eylea-aflibercept-injection-submitted-in-japan-for-marketing-authorization-for-the-treatment-of-wet-age-related-macular-degeneration.html March 3, 2016
http://clinicaspace.com/news/sanofi-france-says-zaltrap-approved-in-europe-for/286672/source=yesterdaysmostpopular January 1, 2015
20+ sources
http://einpresswire.com/article/404247521/sanofi-and-regeneron-announce-positive-study-results-for-dupixent-dupilumab-in-patients-with-moderate-to-severe-atopic-dermatitis October 10, 2017
http://holdthepresses.eu/2017/09/sanofi-and-regeneron-announce-positive.html October 10, 2017
http://mediaroom.sanofi.com/sanofi-and-regeneron-announce-positive-dupilumab-topline-results-from-two-phase-3-trials-in-inadequately-controlled-moderate-to-severe-atopic-dermatitis-patients May 5, 2017
http://benzinga.com/pressreleases/16/10/n8517612/regeneron-and-sanofi-announce-positive-dupixent-dupilumab-phase-3-atopi July 7, 2017
http://prnewswire.com/news-releases/new-survey-reveals-the-widespread-and-serious-impact-of-moderate-to-severe-atopic-dermatitis-on-people-living-with-the-disease-300339368.html August 8, 2017
http://pharmafocusasia.com/pressreleases/regeneron-announces-eu-approval-of-eylea-aflibercept-injection-for-the-treatment-of-visual-impairment-secondary-to-myopic-choroidal-neovascularization January 1, 2016
http://news.sanofigenzyme.com/print/node/3422 February 2, 2017
http://retinalinkglobal.com/regeneron-announces-important-us-prescribing-information-clarification-eylea-aflibercept-injection August 8, 2016
http://news.genzyme.com/press-release/sanofi-and-regeneron-announce-publication-positive-phase-2-dupilumab-data-journal-amer February 2, 2016
http://prnewswire.com/news-releases/sanofi-and-regeneron-to-present-new-data-on-dupixent-dupilumab-for-moderate-to-severe-atopic-dermatitis-at-upcoming-medical-congresses-300413658.html July 7, 2017
http://mediaroom.sanofi.com/sanofi-and-regeneron-announce-dupilumab-biologics-license-application-accepted-for-priority-review-by-u-s-fda May 5, 2017
http://life-sciences-france.com/news/sanofi-regeneron-ph3-results-euronext-san-nyse-sny-2001-107702.html June 6, 2016
http://biospace.com/news/sanofi-and-regeneron-receive-positive-chmp-opinion/463734 September 9, 2017
http://news.genzyme.com/print/node/3320 June 6, 2016
http://news.genzyme.com/press-release/sanofi-and-regeneron-announce-positive-dupilumab-topline-results-two-phase-3-trials-in June 6, 2016
http://news.genzyme.com/press-release/sanofi-and-regeneron-announce-dupilumab-used-topical-corticosteroids-tcs-was-superior- June 6, 2016
http://holdthepresses.eu September 9, 2017
http://life-sciences-europe.com/news/sanofi-regeneron-chmp-recommends-euronext-san-nyse-sny-2001-111062.html September 9, 2017
http://mediaroom.sanofi.com/sanofi-and-regeneron-announce-presentation-of-positive-data-from-long-term-pivotal-phase-3-chronos-study-of-dupixent-dupilumab-in-moderate-to-severe-atopic-dermatitis August 8, 2017
http://mediaroom.sanofi.com/sanofi-et-regeneron-obtiennent-un-avis-favorable-du-chmp-pour-dupixent-dupilumab-dans-le-traitement-de-la-dermatite-atopique-moderee-a-severe-de-ladulte September 9, 2017
http://careers.biospace.com/news/sanofi-and-regeneron-announce-fda-approval-of/450918 September 9, 2017
http://mediaroom.sanofi.com/sanofi-and-regeneron-announce-fda-approval-of-dupixent-dupilumab-the-first-targeted-biologic-therapy-for-adults-with-moderate-to-severe-atopic-dermatitis September 9, 2017
http://prnewswire.com/news-releases/new-survey-of-us-adults-with-diabetes-reveals-less-than-half-understand-their-risk-for-vision-loss-300172899.html September 9, 2017
http://prnewswire.com/news-releases/eylea-aflibercept-injection-receives-approval-in-japan-for-the-treatment-of-retinal-vein-occlusion-300105348.html May 5, 2017
http://news.sanofigenzyme.com/press-release/sanofi-and-regeneron-announce-marketing-authorization-application-dupixent-dupilumab-a February 2, 2017
http://news.sanofigenzyme.com/press-release/new-survey-reveals-widespread-and-serious-impact-moderate-severe-atopic-dermatitis-peo February 2, 2017
http://news.sanofigenzyme.com/press-release/sanofi-and-regeneron-announce-positive-dupixent-dupilumab-phase-3-atopic-dermatitis-da February 2, 2017
http://news.sanofigenzyme.com/press-release/sanofi-and-regeneron-announce-dupilumab-biologics-license-application-accepted-priorit February 2, 2017
http://news.genzyme.com/print/node/3244 February 2, 2016
http://prnewswire.com/news-releases/new-survey-reveals-the-widespread-and-serious-impact-of-moderate-to-severe-atopic-dermatitis-on-people-living-with-the-disease-300339444.html July 7, 2017
20+ sources
http://prnewswire.com/news-releases/regeneron-genetics-center-and-geisinger-study-finds-life-threatening-genetic-disorder-is-substantially-underdiagnosed-300382688.html July 7, 2017
http://prweb.com/releases/2016/02/prweb13208560.htm May 5, 2017
http://mediaroom.sanofi.com/sanofi-et-regeneron-annoncent-le-lancement-dune-etude-de-phase-3-du-dupilumab-dans-le-traitement-de-la-dermatite-atopique-2 July 7, 2017
http://fiercepharma.com/vaccines/regeneron-joins-human-vaccines-project-to-improve-global-disease-prevention-and-treatment November 11, 2016
http://mediaroom.sanofi.com/sanofi-sanofi-and-regeneron-announce-that-dupilumab-has-received-fda-breakthrough-therapy-designation-in-atopic-dermatitis-2 July 7, 2017
http://medimmune.com/about-us/media/medimmune-and-regeneron-enter-into-licensing-agreement-for-the-development-of-antibody-drug-conjugates-to-treat-cancer-05042016.html June 6, 2016
http://intelliatx.com/category/news/page/3 March 3, 2017
http://arthritis.allaboutyourhealth.info/infectious-arthritis/regeneron-and-adicet-bio-announce-strategic-collaboration-to-discover-and-develop-next-generation-engineered.html September 9, 2016
http://mediaroom.sanofi.com/sanofi-sanofi-et-regeneron-annoncent-les-resultats-positifs-dune-etude-de-phase-2b-du-dupilumab-chez-les-patients-souffrant-dasthme-modere-a-severe-2 May 5, 2017
http://societyforscience.org/content/press-room/regeneron September 9, 2016
http://marketwatchedz.tk/story/regeneron-details-royalty-agreement-with-novartis-for-canakinumab-acz885-2017-06-22 July 7, 2017
http://marketwatchedz.tk/story/regeneron-recognized-on-the-civic-50-list-of-the-most-community-minded-companies-in-the-united-states-2017-06-21 July 7, 2017
http://marketwatchedz.tk/story/regeneron-announces-angptl3evinacumab-publication-in-new-england-journal-of-medicine-and-positive-phase-2-data-in-people-with-hofh-2017-05-24 July 7, 2017
http://marketwatchedz.tk/story/regeneron-and-inovio-enter-immuno-oncology-clinical-study-agreement-for-glioblastoma-combination-therapy-2017-05-08 July 7, 2017
http://marketwatchedz.tk/story/inovio-regeneron-enter-immuno-oncology-clinical-study-agreement-for-glioblastoma-combination-therapy-2017-05-08 July 7, 2017
http://biotechstocks.com/tag/biotech-stocks/page/2 June 6, 2016
http://biotechstocks.com/category/biotech-stocks-news/page/2 June 6, 2016
http://biotechstocks.com/tag/best-biotech-stocks/page/2 June 6, 2016
http://biotechstocks.com/tag/biotech-industry-news/page/2 June 6, 2016
http://intelliatx.com/category/news May 5, 2016
http://prnewswire.com/news-releases/regeneron-ceo-leonard-schleifer-and-cso-george-yancopoulos-named-ey-2016-national-life-sciences-entrepreneurs-of-the-year-300366403.html July 7, 2017
http://intelliatx.com/category/news/page/2 January 1, 2017
http://buzzstake.com/regeneron-and-intellia-therapeutics-announce-collaboration-to-discover-and-develop-crisprcas-therapeutics April 4, 2016
http://cmarketwatchez.tk/story/regeneron-announces-angptl3evinacumab-publication-in-new-england-journal-of-medicine-and-positive-phase-2-data-in-people-with-hofh-2017-05-24 May 5, 2017
http://cmarketwatchez.tk/story/regeneron-and-inovio-enter-immuno-oncology-clinical-study-agreement-for-glioblastoma-combination-therapy-2017-05-08 May 5, 2017
http://cmarketwatchez.tk/story/inovio-regeneron-enter-immuno-oncology-clinical-study-agreement-for-glioblastoma-combination-therapy-2017-05-08 May 5, 2017
http://ariva.de/news/regeneron-and-teva-announce-global-collaboration-to-develop-5884164 December 12, 2016
http://tevapharm.com/news/teva_and_regeneron_announce_global_collaboration_to_develop_and_commercialize_fasinumab_an_investigational_ngf_antibody_for_chronic_pain_09_16.aspx October 10, 2016
http://intelliatx.com/regeneron-intellia-therapeutics-announce-collaboration-discover-develop-crisprcas-therapeutics May 5, 2016
http://biotechstocks.com/regn-selected-by-society-for-science June 6, 2016
17 sources
http://newsroom.regeneron.com November 11, 2016
http://newsroom.regeneron.com/releases.cfm July 7, 2017
http://newsroom.regeneron.com/confirm.cfm July 7, 2017
http://bigmovingstock.com/regeneron-pharmaceuticals-regn March 3, 2017
http://investor.regeneron.com/contactus.cfm June 6, 2015
http://thelabrat.com/jobs/companies/regeneron.shtml February 2, 2015
http://thelabrat.com/jobs/companies/Regeneron.shtml July 7, 2015
http://investor.regeneron.com November 11, 2016
http://investor.regeneron.com/stockquote.cfm November 11, 2016
http://investor.regeneron.com/index.cfm November 11, 2016
http://regeneron.com/investor-contact June 6, 2015
http://massagemag.com/regeneron-announces-presentation-at-needham-seventh-annual-biotechnology-and-medical-technology-conference-957 September 9, 2017
http://newsroom.regeneron.com/contactmedia.cfm November 11, 2016
http://investor.regeneron.com/events.cfm November 11, 2016
http://newsroom.regeneron.com/index.cfm November 11, 2016
http://equities.com/companies/regn May 5, 2017
http://drugs.com/clinical_trials/regeneron-bayer-healthcare-announce-vegf-trap-eye-achieved-durable-improvement-vision-over-52-weeks-5314.html February 2, 2015
20+ sources
http://wallstreet-online.de/nachricht/8243085-sanofi-and-regeneron-announce-sarilumab-biologics-license-application-accepted-for-review-by-us-fda December 12, 2016
http://asianhhm.com/pressreleases/regeneron-and-sanofi-announce-approval-of-praluent-alirocumab-for-the-treatment-of-hypercholesterolemia-in-the-european-union September 9, 2015
http://news.sanofigenzyme.com/print/node/3417 February 2, 2017
http://life-sciences-france.com/product/praluent-sanofi-euronext-san-nyse-sny-group-since-2001-25136.html June 6, 2016
http://news.sanofigenzyme.com/press-release/sanofi-and-regeneron-announce-first-approval-kevzaratm-sarilumab-treatment-moderately- February 2, 2017
http://fiercepharma.com/marketing/sanofi-and-regeneron-announce-topline-results-of-phase-3-monotherapy-study-demonstrating November 11, 2016
http://labourseetlavie.com/actualites-economiques-et-financieres-actualites/sanofi-et-regeneron-annoncent-lapprobation-au-japon-de-praluent-alirocumab-dans-le-traitement-de-lhypercholesterolemie November 11, 2016
http://medindia.net/health-press-release/regeneron-presents-positive-interim-data-from-phase-2-proof-of-concept-study-of-evinacumab-in-patients-with-homozygous-familial--289572-1.htm November 11, 2016
http://euroinvestor.fr/actualites/2017/02/08/sanofi-la-cour-dappel-accorde-la-supension-de-linjonction-permanente-visant-praluent-alirocumab-pendant-la-duree-de-la-procedure-dappel/13528975 February 2, 2017
http://life-sciences-france.com/news/sanofi-regeneron-receive-complete-euronext-san-nyse-sny-2001-109248.html November 11, 2016
http://life-sciences-france.com/product/sarilumab-sanofi-euronext-san-nyse-sny-group-since-2001-25591.html June 6, 2016
http://pharmalive.com/regeneron-and-sanofi-announce-approval-of-praluent-alirocumab-for-the-treatment-of-hypercholesterolemia-in-the-european-union May 5, 2016
http://pharmalive.com/regeneron-and-sanofi-announce-approval-of-praluent-alirocumab-for-the-treatment-of-hypercholesterolemia-in-the-european-union/ September 9, 2015
http://news.genzyme.com/print/node/3268 June 6, 2016
http://news.genzyme.com/press-release/sanofi-and-regeneron-announce-topline-results-phase-3-monotherapy-study-demonstrating- June 6, 2016
http://biotechstocks.com/tag/biotech-stock-news June 6, 2016
http://biotechstocks.com/regn-presents-positive-interim-data June 6, 2016
http://biotechstocks.com/tag/best-biotech-stocks June 6, 2016
http://biotechstocks.com/category/biotech-stocks-news June 6, 2016
http://biotechstocks.com/tag/biotech-industry-news June 6, 2016
http://prnewswire.com/news-releases/regeneron-and-sanofi-announce-praluent-alirocumab-marketing-authorization-application-has-been-accepted-for-review-by-ema-300018715.html October 10, 2016
http://asianhhm.com/prnews/regeneron-and-sanofi-announce-approval-of-praluent-alirocumab-for-the-treatment-of-hypercholesterolemia-in-the-european-union September 9, 2015
http://news.genzyme.com/press-release/sanofi-and-regeneron-present-results-phase-3-monarch-study-investigational-sarilumab-a February 2, 2017
http://fiercebiotech.com/biotech/regeneron-and-sanofi-announce-sarilumab-biologics-license-application-accepted-for-review December 12, 2016
http://prnewswire.com/news-releases/sanofi-and-regeneron-announce-unitedhealth-group-selects-praluent-alirocumab-injection-for-preferred-access-300191648.html October 10, 2016
http://research-tree.com/newsfeed/newsrelease/60500 March 3, 2016
http://news.sanofigenzyme.com/press-release/sanofi-and-regeneron-present-results-phase-3-monarch-study-investigational-sarilumab-a February 2, 2017
http://news.sanofigenzyme.com/press-release/sanofi-and-regeneron-receive-complete-response-letter-fda-sarilumab-investigational-tr February 2, 2017
http://news.sanofigenzyme.com/print/node/3438 February 2, 2017
http://news.genzyme.com/press-release/sanofi-and-regeneron-announce-first-approval-kevzaratm-sarilumab-treatment-moderately- February 2, 2017
20+ sources
http://drugs.com/clinical_trials/sanofi-regeneron-report-positive-results-sarilumab-16345.html October 10, 2016
http://prnewswire.com/news-releases/eylea-aflibercept-injection-recommended-for-approval-for-the-treatment-of-visual-impairment-due-to-diabetic-macular-edema-in-the-european-union-264880011.html May 5, 2015
http://bio-medicine.org/medicine-technology-1/sanofi-and-regeneron-announce-patient-enrollment-in-two-phase-3-trials-with-sarilumab-in-rheumatoid-arthritis--28ra-29-32962-1 June 6, 2017
http://macularhope.org/regeneron-highlights-eylea-aflibercept-injection-data-presented-american-academy-ophthalmology-annual-meeting May 5, 2016
http://mediaroom.sanofi.com/sanofi-sanofi-et-regeneron-vont-presenter-des-donnees-cliniques-sur-lalirocumab-aux-63emes-seances-scientifiques-annuelles-de-lamerican-college-of-cardiology-2 August 8, 2017
http://mediaroom.sanofi.com/sanofi-sanofi-and-regeneron-to-present-alirocumab-clinical-data-at-american-college-of-cardiology-63rd-annual-scientific-session July 7, 2017
http://frenchbiobeach.com/join-our-email-list/page/11 April 4, 2016
http://prnewswire.com/news-releases/sanofi-and-regeneron-report-positive-top-line-results-with-alirocumab-from-first-phase-3-study-of-a-pcsk9-inhibitor-for-ldl-cholesterol-reduction-227948681.html April 4, 2015
http://biospace.com/news/sanofi-france-and-regeneron-pharmaceuticals-inc/296756 January 1, 2015
http://biospace.com/news/regeneron-pharmaceuticals-inc-and-bayer-healthcare/304920 January 1, 2015
http://biospace.com/news/regeneron-pharmaceuticals-inc-fda-accepts-sbla-for/318964/source=morenews January 1, 2015
http://thestreet.com/story/12021691/1/eylea-aflibercept-injection-approved-in-europe-for-the-treatment-of-visual-impairment-due-to-macular-edema-secondary-to-central-retinal-vein-occlusion.html October 10, 2016
http://thestreet.com/story/12040321/1/regeneron-to-present-phase-3-data-for-eylea-aflibercept-injection-in-diabetic-macular-edema-at-upcoming-retina-society-meeting.html May 5, 2016
http://newsroom.regeneron.com/releasedetail.cfm April 4, 2015
http://prnewswire.com/news-releases/regeneron-highlights-eylea-aflibercept-injection-data-to-be-presented-at-american-academy-of-ophthalmology-annual-meeting-231629281.html January 1, 2015
http://thestreet.com/story/11999721/1/regeneron-and-bayer-report-positive-one-year-results-from-two-phase-3-trials-of-eylea-aflibercept-injection-for-the-treatment-of-diabetic-macular-edema.html October 10, 2016
http://thestreet.com/story/12466590/3/bayer-healthcare-and-regeneron-announce-regulatory-submission-of-eylea-aflibercept-injection-for-the-treatment-of-diabetic-macular-edema-in-japan.html May 5, 2015
http://bio-medicine.org/medicine-technology-1/sanofi-and-regeneron-report-positive-results-with-sarilumab-in-first-phase-3-rheumatoid-arthritis-registration-trial-37118-1 March 3, 2016
http://frenchbiobeach.com/category/biotech-news/page/4 April 4, 2016
http://investor.regeneron.com/releasedetail.cfm May 5, 2015
http://prnewswire.com/news-releases/two-year-results-from-phase-3-vista-trial-of-eylea-aflibercept-injection-for-the-treatment-of-diabetic-macular-edema-show-sustained-improvement-in-vision-244696531.html February 2, 2015
http://biospace.com/news_story.aspx April 4, 2015
http://thestreet.com/story/12160165/3/sanofi-regeneron-to-collaborate-with-american-college-of-cardiology-for-pcsk9-inhibitor-clinical-program.html January 1, 2015
http://biospace.com/news/sanofi-france-and-regeneron-pharmaceuticals-inc/319187 January 1, 2015
http://drugs.com/clinical_trials/sanofi-regeneron-cuts-ldl-phase-iii-study-16197.html October 10, 2016
http://prnewswire.com/news-releases/sanofi-and-regeneron-to-present-alirocumab-clinical-data-at-the-american-college-of-cardiologys-63rd-annual-scientific-session-252586521.html May 5, 2015
http://frenchbiobeach.com/2013/11/23/sanofi-and-regeneron-report-positive-results-with-sarilumab-in-first-phase-3-rheumatoid-arthritis-registration-trial April 4, 2016
14 sources
http://drugs.com/clinical_trials/vegf-trap-eye-shows-positive-results-phase-2-study-patients-diabetic-macular-edema-8883.html April 4, 2015
http://drugs.com/clinical_trials/regeneron-announces-positive-results-exploratory-proof-concept-study-rilonacept-chronic-active-gout-1904.html January 1, 2015
http://bio-medicine.org/medicine-news-1/regeneron-announces-presentation-at-the-21st-annual-piper-jaffray-healthcare-conference-62019-1 April 4, 2014
http://bio-medicine.org/medicine-technology-1/phase-3-trial-of-aflibercept-in-metastatic-pancreatic-cancer-discontinued-4975-5 February 2, 2015
http://bio-medicine.org/medicine-news-1/regeneron-announces-september-2009-investment-conference-presentations-56871-1 May 5, 2017
http://drugs.com/news/regeneron-closes-312-million-common-stock-sale-connection-sanofi-aventis-collaboration-7451.html April 4, 2015
http://massagemag.com/regeneron-announces-presentation-at-needham-seventh-annual-biotechnology-and-medical-technology-conference-957 September 9, 2017
http://bio-medicine.org/medicine-technology-1/phase-3-trial-of-aflibercept-in-metastatic-pancreatic-cancer-discontinued-4975-1 August 8, 2017
http://newsroom.regeneron.com/releasedetail.cfm April 4, 2015
http://biospace.com/news/regeneron-pharmaceuticals-inc-jobs-sanofi-aventis/162454 January 1, 2015
http://drugs.com/clinical_trials/sanofi-aventis-regeneron-announce-results-phase-2-study-aflibercept-vegf-trap-advanced-ovarian-7528.html January 1, 2015
http://drugs.com/clinical_trials/regeneron-bayer-healthcare-announce-vegf-trap-eye-achieved-durable-improvement-vision-over-52-weeks-5314.html February 2, 2015
http://bio-medicine.org/medicine-technology-1/regeneron-announces-presentation-at-the-deutsche-bank-2009-biotech-boston-confab-6892-1 January 1, 2015
http://medindia.net/health-press-release/regeneron-announces-participation-in-a-panel-discussion-at-rbc-capital-markets-healthcare-conference-62072-1.htm July 7, 2017
5 sources
http://regeneron.com.statstool.com/topsites April 4, 2016
http://regeneron.com.statstool.com/page/country April 4, 2016
http://regeneron.com.statstool.com/page/pagerank April 4, 2016
http://regeneron.com.statstool.com/page/domain April 4, 2016
http://regeneron.com.statstool.com April 4, 2016
1 source
http://mediaroom.sanofi.com/sanofi-et-regeneron-annoncent-lapprobation-de-praluent-alirocumab-dans-lunion-europeenne-pour-le-traitement-de-lhypercholesterolemie-2 May 5, 2017
1 source
http://usgbc.org/organizations/regeneron-pharmaceuticals-inc November 11, 2016

Please log in to uncover the email addresses, access the 152 results for regeneron.com, filters and more.

Create a free account

Already have an account? Sign in

More information about regeneron.com

Industry: Science

Language of the website: English

Main technologies used:

Related companies

Omsi
omsi.edu • 99 email addresses
Hologic
hologic.com • 238 email addresses
Cincinnati Museum Center
cincymuseum.org • 95 email addresses
North Carolina Museum Of Natural Sciences
naturalsciences.org • 273 email addresses
Biogen Science
biogenidec.com • 203 email addresses
Queens Museum
queensmuseum.org • 106 email addresses
Find email addresses from any website

Search contact information of any website in one click.

When you visit a website, click on the icon to find the email addresses related to the website.

image/svg+xml

Hunter is the easiest way to find the email address of any professional. Search any domain name to find instantly the main email format used in an organization and all the email addresses publicly available on the web.

Create a free account

  1. Homepage
  2. Companies directory
  3. Science
  4. Regeneron